The capacity of podoplanin, up-regulated in metastatic tumours, to induce platelet activation and cancer cell arrest and extravasation (47, 48), makes tempting to speculate that CLEC-2-podoplanin interactions might play a role in cancer-associated venous thrombosis. Here, PDPN is linked to neoplasm.